📰 CHINA IS IN TALKS WITH PFIZER INC PFE.N FOR LICENCE TO MANUFACTURE AND DISTRIBUTE A GENERIC VERSION OF THE U.S. FIRM’S COVID-19 ANTIVIRAL DRUG PAXLOVID IN CHINA -SOURCES $PFE